To address the effect of TIMP-1 in chemotherapy, NSCLC A549 and H460 and their TIMP-1 non-target (NT) and knock-down (KD) clones were employed (Supplementary Figure S1A). This evidence concerns the gene TIMP1 and non-small cell lung carcinoma.